Topoisomerase II from Chlorella virus PBCV-1 has an exceptionally high DNA cleavage activity

被引:34
作者
Fortune, JM
Lavrukhin, OV
Gurnon, JR
Van Etten, JL
Lloyd, RS
Osheroff, N
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Med Hematol Oncol, Nashville, TN 37232 USA
[3] Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA
[4] Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA
[5] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA
关键词
D O I
10.1074/jbc.M101693200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chlorella virus PBCV-1 topoisomerase II is the only functional type II enzyme known to be encoded by a virus that infects eukaryotic cells. However, it has not been established whether the protein is expressed following viral infection or whether the enzyme has any catalytic features that distinguish it from cellular type II topoisomerases. Therefore, the present study characterized the physiological expression of PBCV-1 topoisomerase II and individual reaction steps catalyzed by the enzyme. Results indicate that the topoisomerase II gene is widely distributed among Chlorella viruses and that the protein is expressed 60-90 min after viral infection of algal cells. Furthermore, the enzyme has an extremely high DNA cleavage activity that sets it apart from all known eukaryotic type II topoisomerases. Levels of DNA scission generated by the viral enzyme are similar to 30 times greater than those observed with human topoisomerase II alpha, The high levels of cleavage are not due to inordinately tight enzyme-DNA binding or to impaired DNA religation, Thus, they most likely reflect an elevated forward rate of scission. The robust DNA cleavage activity of PBCV-1 topoisomerase II provides a unique tool for studying the catalytic functions of type II topoisomerases.
引用
收藏
页码:24401 / 24408
页数:8
相关论文
共 79 条
[1]  
Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO
[2]  
2-Q
[3]   Mutagenic properties of topoisomerase-targeted drugs [J].
Baguley, BC ;
Ferguson, LR .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :213-222
[4]   DNA NICKING-CLOSING ENZYME ENCAPSIDATED IN VACCINIA VIRUS - PARTIAL-PURIFICATION AND PROPERTIES [J].
BAUER, WR ;
RESSNER, EC ;
KATES, J ;
PATZKE, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (05) :1841-1845
[5]   AFRICAN SWINE FEVER VIRUS ENCODES A GENE WITH EXTENSIVE HOMOLOGY TO TYPE-II DNA TOPOISOMERASES [J].
BAYLIS, SA ;
DIXON, LK ;
VYDELINGUM, S ;
SMITH, GL .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 228 (03) :1003-1010
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme [J].
Burden, DA ;
Osheroff, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :139-154
[8]   CASEIN KINASE-II PHOSPHORYLATES THE EUKARYOTE-SPECIFIC C-TERMINAL DOMAIN OF TOPOISOMERASE-II INVIVO [J].
CARDENAS, ME ;
DANG, Q ;
GLOVER, CVC ;
GASSER, SM .
EMBO JOURNAL, 1992, 11 (05) :1785-1796
[9]  
CARDENAS ME, 1993, J CELL SCI, V104, P533
[10]   PROTEIN-KINASE-C MODULATES THE CATALYTIC ACTIVITY OF TOPOISOMERASE-II BY ENHANCING THE RATE OF ATP HYDROLYSIS - EVIDENCE FOR A COMMON MECHANISM OF REGULATION BY PHOSPHORYLATION [J].
CORBETT, AH ;
FERNALD, AW ;
OSHEROFF, N .
BIOCHEMISTRY, 1993, 32 (08) :2090-2097